Abstract
摘要
相似文献
1
Etoposide.依托泊苷
N Engl J Med. 1985 Aug 22;313(8):518-9. doi: 10.1056/NEJM198508223130815.
2
Oral etoposide in gestational trophoblastic disease.
Cancer Treat Rep. 1984 May;68(5):775-7.
3
Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic disease.口服VP16 - 213作为主要化疗药物治疗妊娠滋养细胞疾病的应用。
Am J Obstet Gynecol. 1984 Dec 15;150(8):924-7. doi: 10.1016/0002-9378(84)90382-x.
4
[Phase II study of etoposide (NK 171) in trophoblastic disease. Study Group on Etoposide (NK 171) for Trophoblastic Disease].依托泊苷（NK 171）治疗滋养细胞疾病的II期研究。滋养细胞疾病依托泊苷（NK 171）研究组
Nihon Gan Chiryo Gakkai Shi. 1986 Jul 20;21(6):1266-76.
5
Pharmacokinetics of etoposide in gestochoriocarcinoma.
Cancer Treat Rep. 1985 Jan;69(1):69-72.
6
Ovarian dysfunction in patients with gestational trophoblastic neoplasia treated with short intensive courses of etoposide (VP-16-213).接受短疗程高强度依托泊苷（VP - 16 - 213）治疗的妊娠滋养细胞肿瘤患者的卵巢功能障碍
Cancer. 1985 May 15;55(10):2348-52. doi: 10.1002/1097-0142(19850515)55:10<2348::aid-cncr2820551009>3.0.co;2-i.
7
[Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].
Dtsch Med Wochenschr. 1981 Aug 28;106(35):1105-9. doi: 10.1055/s-2008-1070465.
8
Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.依托泊苷治疗晚期或复发性子宫内膜癌的II期试验：一项妇科肿瘤学组研究
Cancer Treat Rep. 1982 Aug;66(8):1669-71.
9
Hepatic metastases in gestational trophoblastic disease.
Obstet Gynecol. 1986 Jan;67(1):107-11.
10
Management of high-risk gestational trophoblastic disease.高危妊娠滋养细胞疾病的管理
J Reprod Med. 1998 Jan;43(1):44-52.
Zotero 插件